Home » Topics » BioWorld Science

BioWorld Science
RSS

CAR macrophages with directed antitumor phagocytic activity for cancer immunotherapy

April 21, 2020

A paracrine interaction between breast cancer cells and MAFs promotes metastatic progression

April 21, 2020

FAM13A variants lead to changes in adipocyte differentiation regulation and body fat distribution

April 21, 2020

Sinovac initiates phase I study of its vaccine candidate against COVID-19

April 21, 2020

Eating proinflammatory IgG helps prevent liver failure

April 21, 2020

Fast route from fibroblasts to photoreceptors

April 21, 2020

Kazia updates findings from phase I study of Cantrixil in ovarian cancer

April 20, 2020

Ascendis reports fixed-dose TransCon PTH data from phase II PaTH Forward trial in hypoparathyroidism

April 20, 2020

U.K. MHRA clears 4D Pharma to begin phase II study of MRx-4DP0004 in COVID-19

April 20, 2020

Idorsia reports first pivotal results with daridorexant in insomnia

April 20, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 6, 2026.
CINP 2026: Prenatal and adolescent stress shape brain vulnerability
BioWorld Science
Human biology is extraordinarily complex, and that sophistication emerges from the very beginning. During embryonic and fetal development, the organism’s...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
Neuracle eyes Shanghai IPO as global BCI funding surges
BioWorld
Neuracle Medical Technology Co. Ltd. is seeking a Shanghai IPO that could make it China’s first publicly listed invasive brain-computer interface (BCI) company,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...